Pembrolizumab will be offered to more women in England, to fight aggressive triple-negative tumours.
Digital health editor
Triple-negative tumours account for 15% of all breast-cancer cases but are harder to treat - often with poorer outcomes. NHS England estimates up to 1,600 women a year could benefit from its "confidential" deal with manufacturer MSD.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
NHS Borders monitors high levels of scarlet feverNHS Borders says the number of cases across the region is currently 'unseasonably high'.
Lire la suite »
Keir Starmer: Too many people from overseas recruited to NHSThe Labour leader wants to fix the health service staffing crisis by hiring more people from the UK.
Lire la suite »
Boost for England as Phillips set for Man City return against ChelseaManchester City midfielder Kalvin Phillips will return to their squad for Wednesday's English League Cup game against Chelsea after overcoming a shoulder injury that has kept him out of action since September, manager Pep Guardiola said.
Lire la suite »
Prince William Talks Mental Health in Video Interview with England Soccer Stars'Disappointment is part of life, and how you handle it is crucial.'
Lire la suite »
High-ranking Church of England officials endorse gay marriage: 'Rank heresy'Multiple bishops in the Church of England, including the high-ranking Bishop of Oxford Steven Croft, affirmed gay marriage and called on the institution to bless such unions.
Lire la suite »
Insider: Colts offense collapses completely in horrific loss to New EnglandThe Colts managed just 121 yards of offense and went 0-for-14 on third down in 26-3 loss to the Patriots
Lire la suite »